From June 20 to 22, 2024, the 3rd Linping Biomedicine Source Innovation Conference concluded successfully in Linping, Hangzhou! Our company attended this conference as a conference participant. This conference is jointly sponsored by Zhejiang University School of Basic Medicine, Zhejiang University (Linping) Basic Medical Innovation Institute, Zhejiang Biomedical Society, Yangtze River Delta Biomedicine Collaborative Innovation Alliance, Hangzhou Linping District Biomedicine Association, Zhejian

On March 24, 2022, the State Food and Drug Administration and the National Health Commission issued an announcement on the "Good Management Practices for Clinical Trials of Medical Devices" (No. 28, 2022). In order to deepen the reform of the medical device review and approval system and strengthen the management of clinical trials of medical devices, this announcement is based on the "Regulations on the Supervision and Administration of Medical Devices" (State Council Order No. 739) and the "Me

On August 26, 2021, the State Administration for Market Regulation issued Order No. 47 on the "Medical Device Registration and Filing Management Measures", which will come into effect on October 1, 2021.

On April 23, 2020, the State Food and Drug Administration and the National Health Commission issued an announcement on the release of quality management practices for drug clinical trials (No. 57, 2020). This announcement is to deepen the reform of the drug review and approval system, encourage innovation, and further promote the standardized research and quality improvement of drug clinical trials in my country. The State Food and Drug Administration, together with the National Health Commissio

On January 22, 2020, the State Administration for Market Regulation issued Order No. 27 on the "Measures for the Administration of Drug Registration", which will come into effect on July 1, 2020.